Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Rodent Cerebrovascular Disease Drug Efficacy Evaluation System

Rodent Cerebrovascular Disease Drug Efficacy Evaluation System

Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D.

Rodent Cerebrovascular Disease Drug Efficacy Evaluation System

Cardiovascular and cerebrovascular diseases generally refer to ischemic or hemorrhagic diseases of the heart, brain and systemic tissues caused by hyperlipidemia, blood viscosity, atherosclerosis, and hypertension.
Range of Cerebrovascular Disease
Common Rodent Models for Cerebrovascular Disease

Common Rodent Models for Cerebrovascular Disease.jpg

Ischemic stroke and hemorrhagic stroke are the most commonly used pharmacodynamic evaluation systems for the cerebrovascular system.  Among them, middle cerebral artery occlusion (MCAO) is the key recommended pharmacodynamics evaluation system by the National Institutes of Health (NIH) and the Stroke Treatment Academic Industry Roundtable (STAIR).
Advantages of Medicilon MCAO Model Evaluation System
MCAO Mouse Model Evaluation System - Investigation of Dose-Response and Time-Response Relationship
MCAO Mouse Model Evaluation System - Trement Time Window Investigation
MCAO Mouse Model Evaluation System - Neurological Recovery Investigation
MCAO Rat Model Evaluation System
Return